Glecaprevir/pibrentasvir (Mavyret)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Glecaprevir/pibrentasvir (Mavyret), covering 2024-07-11 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir [Phase 4]